Sequoia Financial Advisors LLC Purchases 7,398 Shares of Colgate-Palmolive (NYSE:CL)

Sequoia Financial Advisors LLC boosted its position in Colgate-Palmolive (NYSE:CL) by 49.2% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 22,423 shares of the company’s stock after buying an additional 7,398 shares during the quarter. Sequoia Financial Advisors LLC’s holdings in Colgate-Palmolive were worth $1,787,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors have also bought and sold shares of CL. &PARTNERS lifted its stake in shares of Colgate-Palmolive by 0.7% during the 4th quarter. &PARTNERS now owns 17,643 shares of the company’s stock valued at $1,406,000 after buying an additional 129 shares in the last quarter. West Branch Capital LLC boosted its stake in shares of Colgate-Palmolive by 24.0% in the fourth quarter. West Branch Capital LLC now owns 682 shares of the company’s stock worth $54,000 after acquiring an additional 132 shares during the period. Gladstone Institutional Advisory LLC grew its position in shares of Colgate-Palmolive by 2.1% during the first quarter. Gladstone Institutional Advisory LLC now owns 6,329 shares of the company’s stock worth $476,000 after purchasing an additional 133 shares in the last quarter. First Foundation Advisors lifted its holdings in Colgate-Palmolive by 2.7% in the 3rd quarter. First Foundation Advisors now owns 5,226 shares of the company’s stock worth $372,000 after purchasing an additional 136 shares in the last quarter. Finally, Waldron Private Wealth LLC boosted its stake in Colgate-Palmolive by 2.7% in the 3rd quarter. Waldron Private Wealth LLC now owns 5,361 shares of the company’s stock worth $381,000 after purchasing an additional 140 shares during the period. Hedge funds and other institutional investors own 80.41% of the company’s stock.

Insider Transactions at Colgate-Palmolive

In other Colgate-Palmolive news, CEO Noel R. Wallace sold 50,000 shares of the company’s stock in a transaction on Monday, February 12th. The stock was sold at an average price of $83.15, for a total value of $4,157,500.00. Following the completion of the sale, the chief executive officer now directly owns 274,179 shares in the company, valued at approximately $22,797,983.85. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. In related news, CEO Noel R. Wallace sold 29,772 shares of the business’s stock in a transaction that occurred on Friday, February 16th. The shares were sold at an average price of $84.06, for a total value of $2,502,634.32. Following the completion of the transaction, the chief executive officer now owns 301,343 shares of the company’s stock, valued at $25,330,892.58. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Noel R. Wallace sold 50,000 shares of the firm’s stock in a transaction dated Monday, February 12th. The stock was sold at an average price of $83.15, for a total value of $4,157,500.00. Following the sale, the chief executive officer now directly owns 274,179 shares in the company, valued at $22,797,983.85. The disclosure for this sale can be found here. Over the last three months, insiders have sold 232,371 shares of company stock valued at $19,505,099. 0.34% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

Several equities analysts have recently commented on the stock. Barclays boosted their target price on shares of Colgate-Palmolive from $82.00 to $84.00 and gave the stock an “equal weight” rating in a report on Friday. UBS Group increased their price objective on shares of Colgate-Palmolive from $93.00 to $95.00 and gave the company a “buy” rating in a report on Monday, January 29th. Morgan Stanley lifted their target price on Colgate-Palmolive from $85.00 to $93.00 and gave the stock an “overweight” rating in a report on Monday, January 29th. Evercore ISI boosted their target price on Colgate-Palmolive from $90.00 to $96.00 and gave the stock an “outperform” rating in a research report on Monday, April 8th. Finally, Raymond James upgraded Colgate-Palmolive from a “market perform” rating to an “outperform” rating and set a $91.00 price target for the company in a report on Monday, January 29th. Three research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $88.56.

Colgate-Palmolive Stock Performance

Colgate-Palmolive stock opened at $85.82 on Friday. The company has a debt-to-equity ratio of 8.59, a current ratio of 1.11 and a quick ratio of 0.71. The firm has a market capitalization of $70.54 billion, a P/E ratio of 30.87, a price-to-earnings-growth ratio of 3.29 and a beta of 0.42. Colgate-Palmolive has a 1-year low of $67.62 and a 1-year high of $90.37. The company’s 50-day moving average is $86.83 and its 200 day moving average is $80.25.

Colgate-Palmolive (NYSE:CL) last released its earnings results on Friday, January 26th. The company reported $0.87 earnings per share for the quarter, topping analysts’ consensus estimates of $0.85 by $0.02. The business had revenue of $4.95 billion for the quarter, compared to analyst estimates of $4.89 billion. Colgate-Palmolive had a return on equity of 509.75% and a net margin of 11.82%. The business’s revenue was up 6.9% compared to the same quarter last year. During the same quarter last year, the firm posted $0.77 earnings per share. Research analysts forecast that Colgate-Palmolive will post 3.49 EPS for the current year.

Colgate-Palmolive Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 15th. Shareholders of record on Monday, April 22nd will be given a $0.50 dividend. This represents a $2.00 annualized dividend and a yield of 2.33%. This is a boost from Colgate-Palmolive’s previous quarterly dividend of $0.48. The ex-dividend date is Friday, April 19th. Colgate-Palmolive’s payout ratio is 69.06%.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.